TickerFacts.

Company research / SGHT

Sight Sciences, Inc. (SGHT)

Build a valuation ↗↓ Download CSV

CIK 0001531177 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Sight Sciences, Inc. reported revenue of $77.36M. Revenue fell 3.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $83.38M.

Key ratios (year ended 2025-12-31)

86.2%
Gross margin
-48.0%
Operating margin
-49.7%
Net margin
-60.1%
Return on year-end equity
-3.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$83.38M$77.36M$79.87M$81.06M$71.33M$48.96M$27.64M
Cost of Revenue$10.04M$10.70M$11.58M$11.88M$12.36M$8.61M$9.21M
Gross Profit$73.34M$66.67M$68.28M$69.17M$58.97M$40.35M$18.43M
R&D Expense$10.85M$14.61M$17.99M$17.56M$22.86M$15.63M$8.87M
Operating Income-$27.87M-$37.10M-$50.53M-$57.27M-$83.95M-$51.48M-$32.19M
Depreciation & Amortization$410.0K$487.0K$712.0K$614.0Kn/an/an/a
EBITDA-$27.46M-$36.61M-$49.82M-$56.66Mn/an/an/a
Net Income-$29.76M-$38.43M-$51.51M-$55.55M-$86.24M-$62.96M-$34.69M
EPS (Diluted)n/a-$0.74-$1.03-$1.14-$1.80-$2.36n/a
Total Assets$104.87M$115.30M$142.84M$166.65M$213.07M$280.19M$72.81M
Total Liabilities$51.98M$51.36M$55.32M$46.44M$53.00M$48.08M$44.32M
Long-Term Debtn/a$42.38M$40.00M$35.00M$35.00M$35.00Mn/a
Shareholders' Equity$52.89M$63.94M$87.52M$120.22M$160.08M$232.11M-$88.85M
Cash & Equivalents$79.75M$91.97M$120.36M$138.13M$185.00M$260.69M$61.51M
Operating Cash Flow-$23.24M-$29.69M-$22.35M-$47.18M-$75.97M-$52.54M-$32.17M
Capital Expenditures$93.0K$224.0K$385.0K$791.0K$970.0K$813.0K$953.0K
Free Cash Flow-$23.33M-$29.92M-$22.74M-$47.98M-$76.94M-$53.35M-$33.13M
Shares Outstanding54.72M53.49M50.94M49.13M48.30M47.50M9.51M
Weighted Average Diluted Sharesn/a52.15M50.13M48.63M47.85M26.73Mn/a
EPS (Basic)n/a-$0.74-$1.03-$1.14-$1.80-$2.36n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView